• Accueil >
  • Publications >
  • Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer

Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer

1 août 2015Annals of Oncology

DOI : 10.1093/annonc/mdv217

Auteurs

F.-C. Bidard, C.K.Y. Ng, P. Cottu, S. Piscuoglio, L. Escalup, R.A. Sakr, F. Reyal, P. Mariani, R. Lim, L. Wang, L. Norton, V. Servois, B. Sigal, A. Vincent-Salomon, B. Weigelt, J.-Y. Pierga, J.S. Reis-Filho